妊娠期高血压疾病的降压启动时机——早期干预降低临床风险

doi:10.12114/j.issn.1007-9572.2022.0517

中国全科医学 ›› 2022, Vol. 25 ›› Issue (30): 3733-3738.DOI: 10.12114/j.issn.1007-9572.2022.0517

所属专题：高血压最新文章合辑；孕产妇健康研究最新文章合辑

妊娠期高血压疾病的降压启动时机——早期干预降低临床风险

黎娜¹, 程文立²^,^*()

1．100029　北京市，中日友好医院保健二部
2．100029　北京市，首都医科大学附属北京安贞医院高血压中心

收稿日期:2022-06-10 修回日期:2022-07-10 出版日期:2022-10-20 发布日期:2022-08-11
通讯作者: 程文立
黎娜，程文立.妊娠期高血压疾病的降压启动时机——早期干预降低临床风险[J].中国全科医学，2022，25（30）：3733-3738. [www.chinagp.net]
作者贡献：黎娜查阅文献，撰写文章；程文立提出研究选题，撰写文章，负责对文章的终审修订，对文章整体负责。

Timing of Antihypertensive Initiation in Gestational Hypertension—Early Intervention Can Reducec Clinical Risk

Na LI¹, Wenli CHENG²^,^*()

1. Second Department of Health Care, China-Japan Friendship Hospital, Beijing 100029, China
2. Hypertension Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China

Received:2022-06-10 Revised:2022-07-10 Published:2022-10-20 Online:2022-08-11
Contact: Wenli CHENG
About author:
LI N, CHENG W L. Timing of antihypertensive initiation in gestational hypertension—early intervention can reduce clinical risk[J]. Chinese General Practice, 2022, 25 (30) : 3733-3738.

分享到

摘要/Abstract

摘要： 妊娠高血压疾病（妊高症）是危害妊娠期女性健康及胎儿成长发育的严重不良因素，妊高症在我国妊娠期女性中的发病率为6%~8%，随着我国生育政策的放开，孕产妇平均年龄较前增大，超重、肥胖、糖尿病等风险因素普遍增加，妊高症的潜在风险较突出。在妊高症的诊断标准方面国际上专家的看法保持较为一致，≥140/90 mm Hg是诊断妊娠高血压的界定值，但妊高症应该何时启动降压治疗，所需的可作为证据的高水平研究较少。近年来各高血压学术组织对妊娠期女性合并慢性高血压的治疗控制目标值的建议也存在较大争议，各国各学会指南对于妊娠期高血压的治疗阈值和降压目标值分歧较大。本文就妊高症的危害、何时启动降压进行了详细阐述，同时对妊高症的早期干预效果及妊高症防治新方法进行分析，旨在为临床妊高症的降压治疗提供参考。

关键词: 高血压，妊娠性, 妊娠高血压, 降压，控制性, 早期干预

Abstract:

Gestational hypertensionis a serious adverse factor that endangers the health of women during pregnancy and the growth and development of the fetus. The incidence of gestational hypertension in pregnant women in China is 6% to 8%, with the liberalization of the fertility policy in China, the average age of pregnant women has increased, and risk factors such as overweight, obesity, and diabetes have generally increased, the potential risk of gestational hypertension is more prominent among them. In the diagnosis of gestational hypertension, the opinions of international experts are relatively consistent that ≥140/90 mm Hg is the threshold for diagnosing gestational hypertension, but there is still few high-level studies can be used as the evidence supporting the time to start antihypertensive treatment. In recent years, the recommendations of various hypertension academic organizations on the treatment and control target value of pregnant women with chronic hypertension have also been controversial. This article elaborates on the harm of gestational hypertension and the time to initiate blood pressure reduction, analyzes the early intervention effect of gestational hypertension and new methods for the prevention and treatment of gestational hypertension, in order to provide clinical evidence for the antihypertensive treatment of gestational hypertension.

Key words: Hypertension, pregnancy-induced, Gestational hypertension, Hypotension, controlled, Early intervention

黎娜,程文立. 妊娠期高血压疾病的降压启动时机——早期干预降低临床风险[J]. 中国全科医学, 2022, 25(30): 3733-3738. DOI: 10.12114/j.issn.1007-9572.2022.0517.
Na LI,Wenli CHENG. Timing of Antihypertensive Initiation in Gestational Hypertension—Early Intervention Can Reducec Clinical Risk[J]. Chinese General Practice, 2022, 25(30): 3733-3738. DOI: 10.12114/j.issn.1007-9572.2022.0517.

参考文献 35

[1]	Report of the national high blood pressure education program working group on high blood pressure in pregnancy[J]. Am J Obstet Gynecol，2000，183(1):S1-22.
[2]	KUKLINA E V, AYALA C, CALLAGHAN W M. Hypertensive disorders and severe obstetric morbidity in the United States[J]. Obstet Gynecol，2009，113(6):1299-1306. DOI：10.1097/AOG.0b013e3181a45b25.
[3]	ZIADEH S, YAHAYA A. Pregnancy outcome at age 40 and older[J]. Arch Gynecol Obstet，2001，265(1):30-33. DOI：10.1007/s004040000122.
[4]	BDOLAH Y, LAM C, RAJAKUMAR A，et al. Twin pregnancy and the risk of preeclampsia：bigger placenta or relative ischemia? [J]. Am J Obstet Gynecol，2008，198(4):428.e1-6. DOI：10.1016/j.ajog.2007.10.783.
[5]	LI F, QIN J B, ZHANG S M，et al. Prevalence of hypertensive disorders in pregnancy in China：a systematic review and meta-analysis[J]. Pregnancy Hypertens，2021，24:13-21. DOI：10.1016/j.preghy.2021.02.001.
[6]	HONIGBERG M C, ZEKAVAT S M, ARAGAM K，et al. Long-term cardiovascular risk in women with hypertension during pregnancy[J]. J Am Coll Cardiol，2019，74(22):2743-2754. DOI：10.1016/j.jacc.2019.09.052.
[7]	WEBSTER K, FISHBURN S, MARESH M，et al. Diagnosis and management of hypertension in pregnancy：summary of updated NICE guidance[J]. BMJ，2019，366:l5119. DOI：10.1136/bmj.l5119.
[8]	STUART J J, TANZ L J, RIMM E B，et al. Cardiovascular risk factors mediate the long-term maternal risk associated with hypertensive disorders of pregnancy[J]. J Am Coll Cardiol，2022，79(19):1901-1913. DOI：10.1016/j.jacc.2022.03.335.
[9]	KITZMILLER J L, FERRARA A, PENG T，et al. Preexisting diabetes and pregnancy[M]. //COWIE C C, CASAGRANDE S S, MENKE A，et al. Diabetes in America. 3rd ed. Bethesda（MD）：National Institute of Diabetes and Digestive and Kidney Diseases （US），2018.
[10]	MICHAEL C H, SEYEDEH M Z, KRISHNA A，et al.Hypertensive disorders of pregnancy are associated with long-term risk of diverse cardiovascular disease[J]. Circulation，2019，140:A10235.
[11]	LEON L J, MCCARTHY F P, DIREK K，et al. Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records：a CALIBER study[J]. Circulation，2019，140(13):1050-1060. DOI：10.1161/CIRCULATIONAHA.118.038080.
[12]	MALEK A M, WILSON D A, TURAN T N，et al. Abstract 050：maternal risk of incident embolism following hypertensive disorders of pregnancy or pre-pregnancy hypertension in south Carolina[J]. Circulation，2021，143(Suppl_1):A050. DOI：10.1161/circ.143.suppl_1.050.
[13]	SCHERES L J J, LIJFERING W M, GROENEWEGEN N F M，et al. Hypertensive complications of pregnancy and risk of venous thromboembolism[J]. Hypertension，2020，75(3):781-787. DOI：10.1161/HYPERTENSIONAHA.119.14280.
[14]	LIU J Y, YIN J Y. Letter by Liu and Yin regarding article，"impact of the 2017 ACC/AHA guideline for high blood pressure on evaluating gestational hypertension-associated risks for newborns and mothers：a retrospective birth cohort study" [J]. Circ Res，2019，125(11):e94-95. DOI：10.1161/CIRCRESAHA.119.316028.
[15]	YANG F, CHEN H, WEI D，et al. Associations of maternal hypertensive disorders during pregnancy with offspring risks of ischemic heart disease and stroke：a Nordic cohort study[J]. Eur Heart J，2021，42(Supplement_1):ehab724.2889. DOI：10.1093/eurheartj/ehab724.2889.
[16]	KHOSLA K, HEIMBERGER S, NIEMAN K M，et al. Long-term cardiovascular disease risk in women after hypertensive disorders of pregnancy：recent advances in hypertension[J]. Hypertension，2021，78(4):927-935. DOI：10.1161/HYPERTENSIONAHA.121.16506.
[17]	WANG Y X, ARVIZU M, RICH-EDWARDS J W，et al. Hypertensive disorders of pregnancy and subsequent risk of premature mortality[J]. J Am Coll Cardiol，2021，77(10):1302-1312. DOI：10.1016/j.jacc.2021.01.018.
[18]	WU D D, GAO L, HUANG O，et al. Increased adverse pregnancy outcomes associated with stage 1 hypertension in a low-risk cohort：evidence from 47 874 cases[J]. Hypertension，2020，75(3):772-780. DOI：10.1161/HYPERTENSIONAHA.119.14252.
[19]	CHOBANIAN A V, BAKRIS G L, BLACK H R，et al. Seventh report of the joint national committee on prevention，detection，evaluation，and treatment of high blood pressure[J]. Hypertension，2003，42(6):1206-1252. DOI：10.1161/01.HYP.0000107251.49515.c2.
[20]	ACOG practice bulletin No.202：gestational hypertension and preeclampsia[J]. Obstet Gynecol，2019，133(1):1. DOI：10.1097/AOG.0000000000003018.
[21]	GAROVIC V D, DECHEND R, EASTERLING T，et al. Hypertension in pregnancy：diagnosis，blood pressure goals，and pharmacotherapy：a scientific statement from the American heart association[J]. Hypertension，2022，79(2):e21-41. DOI：10.1161/HYP.0000000000000208.
[22]	MOUNIER-VEHIER C, AMAR J, BOIVIN J M，et al. Hypertension and pregnancy. Expert consensus statement from the French Society of Hypertension，an affiliate of the French Society of Cardiology[J]. La Presse Médicale，2016，45(7/8):682-699. DOI：10.1016/j.lpm.2016.05.012.
[23]	PAK K J, HU T, FEE C，et al. Acute hypertension：a systematic review and appraisal of guidelines[J]. Ochsner J，2014，14(4):655-663.
[24]	NERENBERG K A, ZARNKE K B, LEUNG A A，et al. Hypertension Canada's 2018 guidelines for diagnosis，risk assessment，prevention，and treatment of hypertension in adults and children[J]. Can J Cardiol，2018，34(5):506-525. DOI：10.1016/j.cjca.2018.02.022.
[25]	中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南（2020）[J]. 中华妇产科杂志，2020，55 (4):227-238. DOI：10.3760/cma.j.cn112141-20200114-00039.
[26]	TITA A T, SZYCHOWSKI J M, BOGGESS K，et al. Treatment for mild chronic hypertension during pregnancy[J]. N Engl J Med，2022，386(19):1781-1792. DOI：10.1056/NEJMoa2201295.
[27]	MARTÍNEZ-HORTELANO J A, CAVERO-REDONDO I, ÁLVAREZ-BUENO C，et al. Interpregnancy weight change and hypertension during pregnancy：a systematic review and meta-analysis[J]. Obstet Gynecol，2020，135(1):68-79. DOI：10.1097/AOG.0000000000003573.
[28]	GAD M M, ABDELDAYEM J, LICHTMAN D，et al. Abstract 16375：the association between pregestational hypertension and cardiovascular events in pregnant females，a population-based study[J]. Circulation，2020，142(Suppl_3):A16375. DOI：10.1161/circ.142.suppl_3.16375.
[29]	MADDALENA A, OPHELIA M, ROHIN R，et al.Effect of cardiovascular risk factors on hypertensive disorders of pregnancy：a mendelian randomization study[J]. Circulation，2021，144:A9129.
[30]	GUNDERSON E P, GREENBERG M, NGUYEN-HUYNH M N，et al. Early pregnancy blood pressure patterns identify risk of hypertensive disorders of pregnancy among racial and ethnic groups[J]. Hypertension，2019，79(3):599-613. DOI：10.52570/NESR.PB242018.SR0101.
[31]	HAUSPURG A, MARSH D J, MCNEIL R B，et al. Association of N-terminal pro-brain natriuretic peptide concentration in early pregnancy with development of hypertensive disorders of pregnancy and future hypertension[J]. JAMA Cardiol，2022，7(3):268-276. DOI：10.1001/jamacardio.2021.5617.
[32]	BADROV M B, PARK S Y, YOO J K，et al. Role of corin in blood pressure regulation in normotensive and hypertensive pregnancy[J]. Hypertension，2019，73(2):432-439. DOI：10.1161/HYPERTENSIONAHA.118.12137.
[33]	SURESH S C, RANA S. Real-world use of biomarkers in management of hypertension during pregnancy：adjunct to clinical care[J]. Hypertension，2021，77(2):472-474. DOI：10.1161/HYPERTENSIONAHA.120.16422.
[34]	RUBLEVSKAYA A, BICHAN N A. Arterial hypertension in pregnant women：the effect of body mass index and smoking[J]. Eur Heart J，2021，42(Supplement_1). DOI：10.1093/eurheartj/ehab724.2893.
[35]	STUART J J, TANZ L J, RIMM E B，et al. Abstract MP63：established cardiovascular disease risk factors mediate the relationship between hypertensive disorders in first pregnancy and maternal cardiovascular disease[J]. Circulation，2020，141(Suppl_1):AMP63. DOI：10.1161/circ.141.suppl_1.mp63.

妊娠期高血压疾病的降压启动时机——早期干预降低临床风险

Timing of Antihypertensive Initiation in Gestational Hypertension—Early Intervention Can Reducec Clinical Risk

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 35

相关文章 10

编辑推荐

Metrics

留言

[1]	代愉恒, 高畅, 梁新袖, 卢莎, 华雯, 郑钜圣, 胡文胜. 妊娠期糖尿病患者肠道菌群特征与妊娠期高血压疾病的关联研究[J]. 中国全科医学, 2024, 27(02): 156-162.
[2]	刘颖宏, 杨晓娟. Takayasu动脉炎妊娠期间临床管理的研究进展[J]. 中国全科医学, 2023, 26(35): 4483-4486.
[3]	马云云, 宋玉磊, 王蒙蒙, 梁晓, 张薛晴, 徐桂华, 杜丹丹, 柏亚妹. 感官功能障碍在认知功能障碍疾病早期识别与干预中的价值与探索[J]. 中国全科医学, 2022, 25(23): 2899-2902.
[4]	刘霜雪, 李琰华. 绝经泌尿生殖综合征治疗方法的研究进展[J]. 中国全科医学, 2021, 24(36): 4665-4670.
[5]	周路路，陆媛，刘亚林，张慧，于德华，唐岚. 轻度认知障碍非药物治疗研究进展[J]. 中国全科医学, 2021, 24(31): 4027-4031.
[6]	冯玲，周舟，杨晓冬，邱玉琴. 我国妊娠期代谢综合征的可视化分析[J]. 中国全科医学, 2018, 21(36): 4439-4444.
[7]	张源，汪志良，许桦，王慧，杨竹洁，彭磊，宋园园，徐光铮，王春燕，张复亮，彭淑颖，迟桂芬，陆爱萍，梅馨纯，申远，李云霞，李刚. 上海社区老年人轻度认知功能损害患病率调查及其影响因素分析[J]. 中国全科医学, 2018, 21(24): 2909-2915.
[8]	丁晓华，刘小玲，张悦，彭晓明. 膳食因素与妊娠期高血压疾病关系的病例对照研究[J]. 中国全科医学, 2015, 18(20): 2468-2471.
[9]	金伟，龚军. 妊娠期高血压疾病对新生儿肾功能的影响研究[J]. 中国全科医学, 2015, 18(20): 2402-2405.
[10]	朱彩丹. 妊娠期高血压患者随机尿蛋白/肌酐比值水平与不良妊娠结局的关系研究[J]. 中国全科医学, 2015, 18(10): 1168-1171.